DONATE
FacebookTwitter
Restore Public Trust
  • Home
  • About
  • News
  • Contact
Restore Public Trust
  • Home
  • About
  • News
  • Contact
Placeholder

ICYMI: The New York Times Editorial Board Questions FDA Approval Process After Restore Public Trust Lawsuit

Lizzy PriceAugust 15, 2019
Restore Public Trust filed suit last week seeking documents about potential involvement by FDA head in his former company’s approval ... Read More
Placeholder

ICYMI: How Kellyanne Conway saved her White House job

Lizzy PriceAugust 13, 2019
“The Trump administration has made a mockery of our ethics laws,” said Lizzy Price, Director of Restore Public Trust. “Time ... Read More
Placeholder

FDA Fast-Tracked Drug From Company That Acting FDA Commissioner Founded; Restore Public Trust Files Suit

Lizzy PriceAugust 8, 2019
WASHINGTON — Following news that G1 Therapeutics’ drug has been fast tracked a second time since it’s founder Ned Sharpless ... Read More
Placeholder

Big Pharma Exec Not Worried About His Industry’s Future Under Trump Administration

Lizzy PriceAugust 8, 2019
Comments Come After Pharmaceutical Q2 Earnings Calls Prove the Drug Industry is Booming Under Trump-Azar WASHINGTON — During an interview ... Read More

Posts navigation

1 … 29 30 31 … 63

Tags Cloud

Alex Azar Big Pharma Boeing CBP Chad Wolf Child separation CMS DHS DOC DOJ DOT Drug pricing Elaine Chao FAA FDA FOIA HHS John Kelly Kirstjen Nielsen Mitch McConnell news polling Press Release Seema Verma Stephen Hahn Wells Fargo Wilbur Ross William Barr
Restore Public Trust
 
  • Home
  • About
  • News
  • Contact
  • Privacy Policy
FacebookTwitter
SITE ARCHIVED:

Restore Public Trust is now Accountable.US. This website will no longer be updated and has been permanently archived. For the latest accountability and transparency updates please visit us at Accountable.US.

—